RXRX
Recursion Pharmaceuticals Inc
4.30$
-7.8%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 21,403.3% | 7,120.4% | 1,918.2% | 811.4% | 964.4% | 1,185.0% | 1,329.8% | 103.0% | 147.2% | 185.9% | 118.0% | 79.3% | 102.6% | 85.2% | 107.7% | 93.0% | 82.8% | 63.9% | 46.3% | 283.6% | 148.0% | 105.5% | 571.8% | 75.6% | 193.0% | 149.8% | 146.7% | |
| -21,303.3% | -7,020.4% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -47.2% | -85.9% | -18.0% | 20.7% | -2.6% | 14.8% | -7.7% | 7.0% | 17.2% | 36.1% | 53.7% | -183.6% | -48.0% | -5.5% | -471.8% | 24.4% | -93.0% | -49.8% | -46.7% | |
| 21,403.3% | 7,120.4% | 1,918.2% | 811.4% | 964.4% | 1,185.0% | 1,329.8% | 1,931.7% | 612.2% | 502.3% | 312.8% | 321.6% | 384.7% | 499.8% | 693.0% | 654.0% | 500.8% | 513.2% | 286.0% | 2,179.9% | 879.2% | 673.4% | 2,339.4% | 234.5% | 1,358.1% | 1,168.4% | 696.2% | |
| 9,268.3% | 2,773.7% | 807.9% | 296.9% | 357.5% | 554.2% | 627.6% | 768.0% | 397.7% | 277.0% | 149.3% | 145.1% | 188.5% | 256.8% | 289.0% | 286.7% | 232.8% | 221.0% | 144.8% | 1,711.1% | 370.6% | 244.2% | 804.4% | 94.7% | 534.5% | 541.5% | 276.0% | |
| 30,571.7% | 9,794.1% | 2,707.2% | 1,102.8% | 1,319.4% | 1,737.2% | 1,956.1% | 2,698.4% | 1,009.3% | 779.0% | 461.3% | 466.6% | 573.2% | 756.6% | 977.8% | 938.2% | 731.3% | 734.2% | 430.8% | 3,890.2% | 1,249.8% | 917.0% | 2,855.7% | 329.2% | 1,892.6% | 1,709.9% | 945.1% | |
| -30,571.7% | -9,794.1% | -2,607.2% | -1,002.8% | -1,219.4% | -1,637.2% | -1,856.1% | -2,598.4% | -1,056.4% | -864.9% | -479.4% | -445.9% | -575.8% | -741.8% | -985.4% | -931.2% | -714.1% | -698.0% | -377.1% | -4,073.8% | -1,297.9% | -922.5% | -3,327.6% | -304.8% | -1,985.6% | -1,759.7% | -991.7% | |
| 501.7% | 229.0% | 46.5% | 9.1% | 10.0% | 100.0% | 8.8% | 0.1% | 0.3% | 0.2% | 0.1% | 0.1% | 0.2% | 0.2% | 0.2% | 0.2% | 0.1% | 2.7% | 2.1% | 13.4% | 3.4% | 2.5% | 16.1% | 0.0% | 5.4% | 4.0% | 2.7% | |
| -30,706.7% | -10,184.4% | -2,769.5% | -1,010.0% | -1,228.7% | -1,736.0% | -1,897.1% | -2,597.3% | -1,056.4% | -856.7% | -463.1% | -420.4% | -538.4% | -696.5% | -920.8% | -913.6% | -683.1% | -680.8% | -366.8% | -3,965.8% | -1,374.3% | -899.8% | -3,135.3% | -304.2% | -1,886.7% | -1,708.0% | -954.3% | |
| 135.0% | 390.3% | 162.3% | -19.0% | 9.3% | 98.9% | 41.0% | 0.8% | 0.0% | -0.2% | -16.3% | -0.1% | -37.4% | -50.3% | 15.9% | -38.2% | -5.8% | -3.6% | 0.6% | 0.2% | -1.1% | – | 0.1% | 0.1% | -71.1% | 0.0% | -8.4% | |
| -30,706.7% | -10,184.4% | -2,769.5% | -1,010.0% | -1,228.7% | -1,736.0% | -1,897.1% | -2,597.3% | -1,056.4% | -856.7% | -463.1% | -420.4% | -538.4% | -696.5% | -920.8% | -875.3% | -677.3% | -677.2% | -366.8% | -3,966.0% | -1,373.3% | -899.8% | -3,135.3% | -304.2% | -1,815.6% | -1,708.0% | -945.9% | |
| -28,643.3% | -9,404.8% | -2,623.5% | -937.3% | -1,162.6% | -1,542.8% | -1,790.9% | -2,494.3% | -1,003.9% | -820.1% | -440.1% | -396.8% | -507.5% | -646.0% | -845.5% | -842.2% | -628.2% | -615.8% | -337.1% | -3,665.3% | -1,239.8% | -772.5% | -2,728.6% | -249.4% | -1,577.3% | -1,467.1% | -810.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.